Maria Toloudi

Maria Toloudi

Auto-generated profile, based on publicly available information

Maria Toloudi

Research Genetic Cancer Centre Ltd. (RGCC Ltd.), Filotas, 53070 Florina, Greece

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2013 in Journal of Signal Transduction
Verified
Journal Article
Open access
PDF file
PAPanagiotis Apostolou
Panagiotis Apostolou
MTMaria Toloudi
Maria Toloudi
EIEleni Ioannou
Eleni Ioannou
MCMarina Chatziioannou
Marina Chatziioannou
EKEleni Kourtidou
Eleni Kourtidou
IPIoannis Papasotiriou
Ioannis Papasotiriou
The AP-1 transcription factor is a heterodimer protein that regulates gene expression in response to a variety of extrinsic stimuli through signal transduction. It is involved in processes including differentiation, proliferation, and apoptosis. Among the genes it regulates are transcription factors that contribute to the stemness phenotype. Cancer stem cells have the ability to self-renew and initiate differentiation into heterogenic cancer cells, which may cause metastasis and relapses. In the present study, we evaluated the effect of AP-1 complexes, as well as the C-FOS and C-JUN genes, in relation to NANOG, OCT3/4, and SOX2 transcription factors. All assays were undertaken with colon cancer stem cells. Knockdown experiments with siRNA were performed for each individual gene as well as their combination. Changes in gene expression were calculated with quantitative polymerase chain reaction experiments, while the effect on cell cycle distribution and apoptosis was studied by flow cytometry. The results differed depending on the percentage of repression, as well as the gene that was suppressed. In all cases, the number of apoptotic cells was increased. These findings indicate that AP-1 may have a crucial role in the maintenance of cancer stem cells.